Synapse - Ping Chi

Results (177)

Intra-patient dose escalation (IPDE) of ripretinib after disease progression in patients with advanced gastrointestinal stromal tumor (GIST): Analyses from the phase 3 INVICTUS study

Meeting Abstract

Zalcberg, J. R.; Heinrich, M. C.; George, S.; Bauer, S.; Schoffski, P.; Serrano, C.; Jones, R. L.; Gelderblom, H.; Attia, S.; D'Amato, G. Z.; more...
Journal of Clinical Oncology (2021)

Fulltext@MSK | Save

A phase 1b study of avelumab plus DCC-3014, a potent and selective inhibitor of colony stimulating factor 1 receptor (CSF1R), in patients with advanced high-grade sarcoma

Meeting Abstract

Rosenbaum, E.; Movva, S.; Kelly, C. M.; Dickson, M. A.; Keohan, M. L.; Gounder, M. M.; Thornton, K. A.; Chi, P.; Chan, J. E.; Nacev, B.; more...
Journal of Clinical Oncology (2021)

Fulltext@MSK | Save

Clinical benefit of ripretinib dose escalation after disease progression in advanced gastrointestinal stromal tumor: An analysis of the INVICTUS Study

Journal Article

Zalcberg, J. R.; Heinrich, M. C.; George, S.; Bauer, S.; Schöffski, P.; Serrano, C.; Gelderblom, H.; Jones, R. L.; Attia, S.; D'Amato, G.; more...
The Oncologist (2021)

Fulltext@MSK | Save

Ripretinib as ≥4th-line treatment in patients with advanced gastrointestinal stromal tumor: Long-term update from the phase III INVICTUS study

Meeting Abstract

von Mehren, M.; Heinrich, C.; George, S.; Zalcberg, J. R.; Bauer, S.; Gelderblom, H.; Schöffski, P.; Serrano, C.; Jones, R. L.; Attia, S.; more...
Annals of Oncology (2021)

Fulltext@MSK | Save

Biomarkers of response and hyperprogression in patients with sarcoma treated with checkpoint blockade

Meeting Abstract

Klemen, N. D.; Hwang, S.; Bradic, M.; Rosenbaum, E.; Dickson, M.; Gounder, M.; Kelly, C. M.; Keohan, M. L.; Movva, S.; Thornton, K.; more...
Annals of Oncology (2021)

Fulltext@MSK | Save

Phase I study of ripretinib, a broad-spectrum KIT and PDGFRA inhibitor, in patients with KIT-mutated or KIT-amplified melanoma

Meeting Abstract

Janku, F.; Bauer, S.; Shoumariyeh, K.; Jones, R. L.; Spreafico, A.; Jennings, J.; Psoinos, C.; Meade, J.; Ruiz-Soto, R.; Chi, P.
Annals of Oncology (2021)

Fulltext@MSK | Save

Gastrointestinal stromal tumors with BRAF gene fusions. A report of two cases showing low or absent KIT expression resulting in diagnostic pitfalls

Journal Article

Torrence, D.; Xie, Z.; Zhang, L.; Chi, P.; Antonescu, C. R.
Genes Chromosomes and Cancer (2021)

Fulltext@MSK | Save

Population pharmacokinetics of ripretinib in patients with advanced malignancies

Meeting Abstract

George, S.; Janku, F.; Chi, P.; von Mehren, M.; Somaiah, N.; Gelderblom, H.; Jones, R. L.; Allard, M.; Taylor, A.; Li, X.; more...
Cancer Research (2021)

Fulltext@MSK | Save

Ripretinib intrapatient dose escalation after disease progression provides clinically meaningful outcomes in advanced gastrointestinal stromal tumour

Journal Article

George, S.; Chi, P.; Heinrich, M. C.; von Mehren, M.; Jones, R. L.; Ganjoo, K.; Trent, J.; Gelderblom, H.; Razak, A. A.; Gordon, M. S.; more...
European Journal of Cancer (2021)

Fulltext@MSK | Save

Dermatopathological review of cutaneous squamous cell carcinoma events in patients with gastrointestinal stromal tumors treated with ripretinib

Meeting Abstract

Patel, A.; George, S.; Janku, F.; Ganjoo, K.; Young, R.; Chi, P.; Westwood, D.; Stearns, S.; Meade, J.; Ruiz-Soto, R.; more...
Annals of Oncology (2021)

Fulltext@MSK | Save